Skip to main content
Top
Published in: BMC Gastroenterology 1/2014

Open Access 01-12-2014 | Research article

Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents

Authors: Tomoaki Matsumura, Makoto Arai, Daisuke Maruoka, Kenichiro Okimoto, Shoko Minemura, Hideaki Ishigami, Keiko Saito, Tomoo Nakagawa, Tatsuro Katsuno, Osamu Yokosuka

Published in: BMC Gastroenterology | Issue 1/2014

Login to get access

Abstract

Background

Endoscopic submucosal dissection (ESD) has become widely accepted as a standard treatment for gastric epithelial neoplasms. Antithrombotic agents are widely used to prevent thromboembolic disease. However, the feasibility of endoscopic procedures for patients using such agents has been rarely investigated. The aim of this study was to identify risk factors for post-operative bleeding after gastric ESD and to evaluate the relationship between the use of antithrombotic agents and post-operative bleeding.

Methods

From June 2005 to March 2014, 413 patients with 425 gastric neoplasms were treated by ESD. The demographic and clinical parameters associated with post-operative bleeding were investigated. 83 patients receiving antithrombotic agents were separately assessed using various methods of administration during the ESD procedure. Post-operative bleeding that occurred within 5 days of ESD was defined as early post-operative bleeding, whereas subsequent bleeding was defined as delayed bleeding.

Results

The overall post-operative bleeding rate was 4.7%. In patients with continued low-dose aspirin (LDA), heparin replacement (HR), or continued LDA along with HR, post-operative bleeding rates were 9.5%, 23.8%, and 25.0%, respectively. On multivariate analysis, a specimen size of ≥40 mm was a risk factor for early post-operative bleeding [odds ratio (OR) 6.08, 95% CI: 1.74–21.27], and HR and chronic kidney disease (CKD) requiring hemodialysis were risk factors for delayed bleeding (OR 12.23, 95% CI: 2.63–56.77 and OR 28.35, 95% CI: 4.67–172.11, respectively). Continued LDA was not a risk factor for post-operative bleeding.

Conclusions

Large specimen size is a risk factor for early post-operative bleeding, and HR and CKD requiring hemodialysis are risk factors for delayed bleeding. Patients with risk factors should be carefully watched, allowing for the timing of post-operative bleeding after ESD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y: Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000, 3: 219-225. 10.1007/PL00011720.CrossRefPubMed Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y: Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000, 3: 219-225. 10.1007/PL00011720.CrossRefPubMed
2.
go back to reference Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, Kobayashi K, Hashimoto T, Yamamichi N, Tateishi A, Shimizu Y, Oka M, Ogura K, Kawabe T, Ichinose M, Omata M: Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006, 63: 243-249. 10.1016/j.gie.2005.08.002.CrossRefPubMed Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, Kobayashi K, Hashimoto T, Yamamichi N, Tateishi A, Shimizu Y, Oka M, Ogura K, Kawabe T, Ichinose M, Omata M: Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006, 63: 243-249. 10.1016/j.gie.2005.08.002.CrossRefPubMed
3.
go back to reference Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, Yoshihara M, Chayama K: Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc. 2006, 64: 877-883. 10.1016/j.gie.2006.03.932.CrossRefPubMed Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, Yoshihara M, Chayama K: Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc. 2006, 64: 877-883. 10.1016/j.gie.2006.03.932.CrossRefPubMed
4.
go back to reference Nakamoto S, Sakai Y, Kasanuki J, Kondo F, Ooka Y, Kato K, Arai M, Suzuki T, Matsumura T, Bekku D, Ito K, Tanaka T, Yokosuka O: Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. Endoscopy. 2009, 41: 746-750. 10.1055/s-0029-1215010.CrossRefPubMed Nakamoto S, Sakai Y, Kasanuki J, Kondo F, Ooka Y, Kato K, Arai M, Suzuki T, Matsumura T, Bekku D, Ito K, Tanaka T, Yokosuka O: Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. Endoscopy. 2009, 41: 746-750. 10.1055/s-0029-1215010.CrossRefPubMed
5.
go back to reference Antithrombotic Trialists’ Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324 (7329): 71-86. 10.1136/bmj.324.7329.71.CrossRef Antithrombotic Trialists’ Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324 (7329): 71-86. 10.1136/bmj.324.7329.71.CrossRef
6.
go back to reference Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146: 857-867. 10.7326/0003-4819-146-12-200706190-00007.CrossRefPubMed Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146: 857-867. 10.7326/0003-4819-146-12-200706190-00007.CrossRefPubMed
7.
go back to reference Laine L: Review article: gastrointestinal bleeding with low-dose aspirin - what’s the risk?. Aliment Pharmacol Ther. 2006, 24: 897-908. 10.1111/j.1365-2036.2006.03077.x.CrossRefPubMed Laine L: Review article: gastrointestinal bleeding with low-dose aspirin - what’s the risk?. Aliment Pharmacol Ther. 2006, 24: 897-908. 10.1111/j.1365-2036.2006.03077.x.CrossRefPubMed
8.
go back to reference McQuaid KR, Laine L: Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006, 119: 624-638. 10.1016/j.amjmed.2005.10.039.CrossRefPubMed McQuaid KR, Laine L: Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006, 119: 624-638. 10.1016/j.amjmed.2005.10.039.CrossRefPubMed
9.
go back to reference Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A, Antithrombotic Trialists’ (ATT) Collaboration: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009, 373: 1849-1860.CrossRefPubMed Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A, Antithrombotic Trialists’ (ATT) Collaboration: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009, 373: 1849-1860.CrossRefPubMed
10.
go back to reference Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sáinz R: Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther. 2002, 16: 779-786. 10.1046/j.1365-2036.2002.01230.x.CrossRefPubMed Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sáinz R: Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther. 2002, 16: 779-786. 10.1046/j.1365-2036.2002.01230.x.CrossRefPubMed
11.
go back to reference Goto O, Fujishiro M, Oda I, Kakushima N, Yamamoto Y, Tsuji Y, Ohata K, Fujiwara T, Fujiwara J, Ishii N, Yokoi C, Miyamoto S, Itoh T, Morishita S, Gotoda T, Koike K: A multicenter survey of the management after gastric endoscopic submucosal dissection related to postoperative bleeding. Dig Dis Sci. 2012, 57: 435-439. 10.1007/s10620-011-1886-5.CrossRefPubMed Goto O, Fujishiro M, Oda I, Kakushima N, Yamamoto Y, Tsuji Y, Ohata K, Fujiwara T, Fujiwara J, Ishii N, Yokoi C, Miyamoto S, Itoh T, Morishita S, Gotoda T, Koike K: A multicenter survey of the management after gastric endoscopic submucosal dissection related to postoperative bleeding. Dig Dis Sci. 2012, 57: 435-439. 10.1007/s10620-011-1886-5.CrossRefPubMed
12.
go back to reference Watanabe K, Ogata S, Kawazoe S, Watanabe K, Koyama T, Kajiwara T, Shimoda Y, Takase Y, Irie K, Mizuguchi M, Tsunada S, Iwakiri R, Fujimoto K: Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc. 2006, 63: 776-782. 10.1016/j.gie.2005.08.049.CrossRefPubMed Watanabe K, Ogata S, Kawazoe S, Watanabe K, Koyama T, Kajiwara T, Shimoda Y, Takase Y, Irie K, Mizuguchi M, Tsunada S, Iwakiri R, Fujimoto K: Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc. 2006, 63: 776-782. 10.1016/j.gie.2005.08.049.CrossRefPubMed
13.
go back to reference Takizawa K, Oda I, Gotoda T, Yokoi C, Matsuda T, Saito Y, Saito D, Ono H: Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection and analysis of risk factors. Endoscopy. 2008, 40: 179-183. 10.1055/s-2007-995530.CrossRefPubMed Takizawa K, Oda I, Gotoda T, Yokoi C, Matsuda T, Saito Y, Saito D, Ono H: Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection and analysis of risk factors. Endoscopy. 2008, 40: 179-183. 10.1055/s-2007-995530.CrossRefPubMed
14.
go back to reference Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, Omata M: Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agents. Dig Liver Dis. 2009, 41: 725-728. 10.1016/j.dld.2009.01.007.CrossRefPubMed Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, Omata M: Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agents. Dig Liver Dis. 2009, 41: 725-728. 10.1016/j.dld.2009.01.007.CrossRefPubMed
15.
go back to reference Anderson MA, Ben-Menachem T, Gan SI, Gan SI, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Lichtenstein DR, Maple JT, Shen B, Strohmeyer L, Baron T, Dominitz JA: Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009, 70: 1060-1070. 10.1016/j.gie.2009.09.040.CrossRefPubMed Anderson MA, Ben-Menachem T, Gan SI, Gan SI, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Lichtenstein DR, Maple JT, Shen B, Strohmeyer L, Baron T, Dominitz JA: Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009, 70: 1060-1070. 10.1016/j.gie.2009.09.040.CrossRefPubMed
16.
go back to reference Boustière C, Veitch A, Vanbiervliet G, Bulois P, Deprez P, Laquiere A, Laugier R, Lesur G, Mosler P, Nalet B, Napoleon B, Rembacken B, Ajzenberg N, Collet JP, Baron T, Dumonceau JM, European Society of Gastrointestinal Endoscopy: Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2011, 43: 445-461. 10.1055/s-0030-1256317.CrossRefPubMed Boustière C, Veitch A, Vanbiervliet G, Bulois P, Deprez P, Laquiere A, Laugier R, Lesur G, Mosler P, Nalet B, Napoleon B, Rembacken B, Ajzenberg N, Collet JP, Baron T, Dumonceau JM, European Society of Gastrointestinal Endoscopy: Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2011, 43: 445-461. 10.1055/s-0030-1256317.CrossRefPubMed
17.
go back to reference Fujimoto K, Fujishiro M, Katou M, Higuchi K, Iwakiri R, Sakamoto C, Uchiyama S, Kashiwagi A, Ogawa H, Murakami K, Mine T, Yoshino J, Kinoshita Y, Ichinose M, Matsui T: Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Gastroenterol Endosc. 2012, 54: 2073-2102. (in Japanese) Fujimoto K, Fujishiro M, Katou M, Higuchi K, Iwakiri R, Sakamoto C, Uchiyama S, Kashiwagi A, Ogawa H, Murakami K, Mine T, Yoshino J, Kinoshita Y, Ichinose M, Matsui T: Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Gastroenterol Endosc. 2012, 54: 2073-2102. (in Japanese)
18.
go back to reference Fujimoto K, Fujishiro M, Kato M, Higuchi K, Iwakiri R, Sakamoto C, Uchiyama S, Kashiwagi A, Ogawa H, Murakami K, Mine T, Yoshino J, Kinoshita Y, Ichinose M, Matsui T: Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014, 26: 1-14.CrossRefPubMed Fujimoto K, Fujishiro M, Kato M, Higuchi K, Iwakiri R, Sakamoto C, Uchiyama S, Kashiwagi A, Ogawa H, Murakami K, Mine T, Yoshino J, Kinoshita Y, Ichinose M, Matsui T: Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014, 26: 1-14.CrossRefPubMed
19.
go back to reference Cho SJ, Choi IJ, Kim CG, Lee JY, Nam BH, Kwak MH, Kim HJ, Ryu KW, Lee JH, Kim YW: Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy. 2012, 44: 114-121.CrossRefPubMed Cho SJ, Choi IJ, Kim CG, Lee JY, Nam BH, Kwak MH, Kim HJ, Ryu KW, Lee JH, Kim YW: Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy. 2012, 44: 114-121.CrossRefPubMed
20.
go back to reference Sanomura Y, Oka S, Tanaka S, Numata N, Higashiyama M, Kanao H, Yoshida S, Ueno Y, Chayama K: Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastric Cancer. 2014, 17: 489-496. 10.1007/s10120-013-0305-3.CrossRefPubMed Sanomura Y, Oka S, Tanaka S, Numata N, Higashiyama M, Kanao H, Yoshida S, Ueno Y, Chayama K: Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastric Cancer. 2014, 17: 489-496. 10.1007/s10120-013-0305-3.CrossRefPubMed
21.
go back to reference Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011, 14: 101-112.CrossRef Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011, 14: 101-112.CrossRef
22.
go back to reference Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011, 14: 113-123.CrossRef Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011, 14: 113-123.CrossRef
23.
go back to reference Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK: Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010, 152: 1-9. 10.7326/0003-4819-152-1-201001050-00179.CrossRefPubMed Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK: Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010, 152: 1-9. 10.7326/0003-4819-152-1-201001050-00179.CrossRefPubMed
24.
go back to reference Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J: Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005, 62: 1217-1220. 10.1001/archneur.62.8.1217.CrossRefPubMed Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J: Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005, 62: 1217-1220. 10.1001/archneur.62.8.1217.CrossRefPubMed
25.
go back to reference Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G: A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006, 27: 2667-2674. 10.1093/eurheartj/ehl334.CrossRefPubMed Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G: A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006, 27: 2667-2674. 10.1093/eurheartj/ehl334.CrossRefPubMed
26.
go back to reference Sibon I, Orgogozo JM: Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004, 62: 1187-1189. 10.1212/01.WNL.0000118288.04483.02.CrossRefPubMed Sibon I, Orgogozo JM: Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004, 62: 1187-1189. 10.1212/01.WNL.0000118288.04483.02.CrossRefPubMed
27.
go back to reference Koh R, Hirasawa K, Yahara S, Oka H, Sugimori K, Morimoto M, Numata K, Kokawa A, Sasaki T, Nozawa A, Taguri M, Morita S, Maeda S, Tanaka K: Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc. 2013, 78: 476-483. 10.1016/j.gie.2013.03.008.CrossRefPubMed Koh R, Hirasawa K, Yahara S, Oka H, Sugimori K, Morimoto M, Numata K, Kokawa A, Sasaki T, Nozawa A, Taguri M, Morita S, Maeda S, Tanaka K: Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc. 2013, 78: 476-483. 10.1016/j.gie.2013.03.008.CrossRefPubMed
28.
go back to reference Takeuchi T, Ota K, Harada S, Edogawa S, Kojima Y, Tokioka S, Umegaki E, Higuchi K: The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol. 2013, 13: 136-10.1186/1471-230X-13-136.CrossRefPubMedPubMedCentral Takeuchi T, Ota K, Harada S, Edogawa S, Kojima Y, Tokioka S, Umegaki E, Higuchi K: The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol. 2013, 13: 136-10.1186/1471-230X-13-136.CrossRefPubMedPubMedCentral
29.
go back to reference Kakushima N, Yahagi N, Fujishiro M: The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Dig Endosc. 2004, 16: 327-331. 10.1111/j.1443-1661.2004.00413.x.CrossRef Kakushima N, Yahagi N, Fujishiro M: The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Dig Endosc. 2004, 16: 327-331. 10.1111/j.1443-1661.2004.00413.x.CrossRef
30.
go back to reference Kakushima N, Fujishiro M, Kodashima S, Kobayashi K, Tateishi A, Iguchi M, Imagawa A, Motoi T, Yahagi N, Omata M: Histopathologic characteristics of gastric ulcers created by endoscopic submucosal dissection. Endoscopy. 2006, 38: 412-415. 10.1055/s-2006-925166.CrossRefPubMed Kakushima N, Fujishiro M, Kodashima S, Kobayashi K, Tateishi A, Iguchi M, Imagawa A, Motoi T, Yahagi N, Omata M: Histopathologic characteristics of gastric ulcers created by endoscopic submucosal dissection. Endoscopy. 2006, 38: 412-415. 10.1055/s-2006-925166.CrossRefPubMed
31.
go back to reference Goto O, Fujishiro M, Kodashima S, Minatsuki C, Niimi K, Ono S, Yamamichi N, Koike K: Short-Term Healing Process of Artificial Ulcers after Gastric Endoscopic Submucosal Dissection. Gut Liver. 2011, 5: 293-297. 10.5009/gnl.2011.5.3.293.CrossRefPubMedPubMedCentral Goto O, Fujishiro M, Kodashima S, Minatsuki C, Niimi K, Ono S, Yamamichi N, Koike K: Short-Term Healing Process of Artificial Ulcers after Gastric Endoscopic Submucosal Dissection. Gut Liver. 2011, 5: 293-297. 10.5009/gnl.2011.5.3.293.CrossRefPubMedPubMedCentral
32.
go back to reference Yoshio T, Nishida T, Kawai N, Yuguchi K, Yamada T, Yabuta T, Komori M, Yamaguchi S, Kitamura S, Iijima H, Tsutsui S, Michida T, Mita E, Tsujii M, Takehara T: Gastric ESD under Heparin Replacement at High-Risk Patients of Thromboembolism Is Technically Feasible but Has a High Risk of Delayed Bleeding: Osaka University ESD Study Group. Gastroenterol Res Pract. 2013, 2013: 365830-CrossRefPubMedPubMedCentral Yoshio T, Nishida T, Kawai N, Yuguchi K, Yamada T, Yabuta T, Komori M, Yamaguchi S, Kitamura S, Iijima H, Tsutsui S, Michida T, Mita E, Tsujii M, Takehara T: Gastric ESD under Heparin Replacement at High-Risk Patients of Thromboembolism Is Technically Feasible but Has a High Risk of Delayed Bleeding: Osaka University ESD Study Group. Gastroenterol Res Pract. 2013, 2013: 365830-CrossRefPubMedPubMedCentral
33.
go back to reference Ryu HY, Kim JW, Kim HS, Park HJ, Jeon HK, Park SY, Kim BR, Lang CC, Won SH: Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis. Gastrointest Endosc. 2013, 78: 285-294. 10.1016/j.gie.2013.02.008.CrossRefPubMed Ryu HY, Kim JW, Kim HS, Park HJ, Jeon HK, Park SY, Kim BR, Lang CC, Won SH: Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis. Gastrointest Endosc. 2013, 78: 285-294. 10.1016/j.gie.2013.02.008.CrossRefPubMed
Metadata
Title
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
Authors
Tomoaki Matsumura
Makoto Arai
Daisuke Maruoka
Kenichiro Okimoto
Shoko Minemura
Hideaki Ishigami
Keiko Saito
Tomoo Nakagawa
Tatsuro Katsuno
Osamu Yokosuka
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2014
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-14-172

Other articles of this Issue 1/2014

BMC Gastroenterology 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.